Investment Banking

US government shutdown freezes IPO market

Biotech firms could be put in the most perilous position by the closure of the SEC

The government shutdown is threatening to spoil what was poised to be a banner year for IPOs.

The partial closure of the Securities and Exchange Commission is forcing companies that were seeking to list shares in January to push back their plans, according to bankers and lawyers. They include biotechnology firms Gossamer Bio, Alector and Blackstone’s Alight Solutions.

WSJ Logo